cannabinoids

Medical cannabis use in Germany has expanded enormously since the liberalisation of 2017, with cannabinoids finding an increasing range of applications in medicine. The topic is being discussed alongside broader news around cannabis, hemp and the medical facets of cannabinoids, reflecting continued public and professional interest in how medical cannabis is being prescribed and used since the rules were relaxed.

Ukraine has issued medical cannabis-based medication to a cancer patient for the first time, a milestone in the country's move to legalise cannabinoid therapy. The change follows Ukraine's 2024 decision to permit medical cannabis, and the first prescription marks the practical start of access for patients undergoing cancer treatment. It is being discussed as a significant step for Ukrainian healthcare amid the war.

A German-language science explainer on cannabis is circulating online, outlining what cannabinoids actually are. It describes them as bioactive molecules that either occur mainly in the cannabis plant, so-called phytocannabinoids, or are produced naturally by the human body. The post is aimed at general readers curious about the science behind cannabis, its compounds and how they interact with the body.

Northwestern University researchers have identified the brain cells that drive anxiety following cannabinoid exposure, according to a newly announced study. The finding offers a clearer picture of how cannabinoids can trigger anxious responses in the brain and may inform future research on cannabis-related mental health effects and potential treatments for cannabinoid-linked anxiety.

A new infographic under the tag Cannabinoids in Context lays out each cannabinoid alongside the medical conditions it is thought to treat most effectively, with supporting background information for each entry. The aim is to give readers a full system view rather than isolated facts, helping them compare compounds and their potential uses. It is being shared and reshared in health-focused online discussions.

A German-language post is drawing attention to the endocannabinoid system, described as a little-known regulatory network that every human carries. It presents the system as part of neurobiology research, saying it regulates processes such as pain and other bodily functions. The topic is circulating under a science label, prompting discussion about a biological system that few people are familiar with despite its central role in the body.

German-language health discussions are highlighting cannabis and the endocannabinoid system's role in regulating stress reactions, particularly for people dealing with stress and burnout. The claims are attributed to biochemist Dr. Nadine Herwig, who leads research on the topic. Engagement so far is minimal, with the discussion circulating in small health-focused communities online.

Researchers have identified specific neurons in mice that generate anxiety following exposure to cannabinoid drugs. The finding, reported by Genetic Engineering and Biotechnology News, offers a biological explanation for the anxiety side effects some cannabis users experience. The work may help guide development of cannabinoid-based therapies that avoid triggering anxious responses, as debate continues over medicinal cannabis use.